Cite
HARVARD Citation
Wang, C. et al. (2020). Predicting Cost‐Effectiveness of Generic vs. Brand Dabigatran Using Pharmacometric Estimates Among Patients with Atrial Fibrillation in the United States. Clinical and translational science. 13 (2), pp. 352-361. [Online].